EP4129330
SAMSETNINGAR OG AÐFERÐIR BLENDINGSSMÍÐA Í BÓLUEFNI VIÐ DENGUE-VEIRU
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
12.3.2014EP published:
6.9.2023EP application number:
22182269.5
EP translation filed:
29.11.2023Grant published:
15.1.2024EPO information:
European Patent Register
Max expiry date:
11.3.2034Expiry date:
11.3.2027Next due date:
31.3.2027
Title in English:
COMPOSITIONS AND METHODS FOR DENGUE VIRUS CHIMERIC CONSTRUCTS IN VACCINESLanguage of the patent:
English
Timeline
Today
12.3.2014EP application
6.9.2023EP Publication
29.11.2023Translation submitted
15.1.2024Registration published
11.3.2027Expires
Owner
Name:
Takeda Vaccines, Inc.Address:
75 Sidney Street, Cambridge, MA 02139, US
Name:
The Government of The United States of America as represented by The Secretary of The Department of Health and Human ServicesAddress:
4770 Buford Highway Technology Transfer Office (K79), Atlanta, GA 30341, US
Inventor
Name:
STINCHCOMB, Dan T.Address:
Fort Collins, 80528, US
Name:
KINNEY, ClaireAddress:
Fort Collins, 80526, US
Name:
KINNEY, Richard M.Address:
Fort Collins, 80526, US
Name:
LIVENGOOD, Jill A.Address:
Cambridge, 02139, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201361800204 PDate:
15.3.2013Country:
US
Supplementary protection
SPC number:
SPC454
Classification
Categories:
A61K 39/12
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 5.3.2024
Expires: 11.3.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 4.3.2025
Expires: 11.3.2026
Payer: Árnason Faktor ehf.
Number: 13
Paid: 12.3.2026
Expires: 11.3.2027
Payer: Árnason Faktor ehf.